FDA takes Zantac off the shelves
posted: Apr. 15, 2020.
The Food and Drug Adminstration has requested all prescription and over-the-counter ranitidine be removed from the market due to the potential for N-Nitrosodimethylamine (NDMA) contamination. Extended exposure to NDMA at high levels can increase the risk of cancer.